Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.08.2022 | Case report

Catequentinib/nedaplatin/paclitaxel

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhai C-Y, et al. Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. World Journal of Clinical Cases 10: 7474-7482, No. 21, 26 Jul 2022. Available from: URL: http://doi.org/10.12998/wjcc.v10.i21.7474 Zhai C-Y, et al. Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. World Journal of Clinical Cases 10: 7474-7482, No. 21, 26 Jul 2022. Available from: URL: http://​doi.​org/​10.​12998/​wjcc.​v10.​i21.​7474
Metadaten
Titel
Catequentinib/nedaplatin/paclitaxel
Various toxicities: case report
Publikationsdatum
01.08.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-21110-3

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Amitriptyline

Case report

Antineoplastics

Case report

Meropenem

Case report

Azd-1222

Case report

Caffeine

Case report

Alum